GSTM1, GSTM3 and GSTT1 gene variants and risk of benign prostate hyperplasia in North India

Disease Markers

Volumn 26, Issue 2, 2009, Pages 85-91

  Mittal, Rama Devi ^a   Kesarwani, Pravin ^a   Singh, Ranjana ^a   Ahirwar, Dinesh ^a   Mandhani, Anil ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Benign prostate hyperplasia; Genotype; Glutathione S transferases; Multiplex PCR; Polymorphism; Smoking

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE T1; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; GSTM3 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; INDIA; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR; CASE CONTROL STUDY; COMPARATIVE STUDY; DRINKING BEHAVIOR; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SMOKELESS TOBACCO; SMOKING;

NICOTIANA TABACUM;

ALCOHOL DRINKING; CASE-CONTROL STUDIES; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INDIA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS; PROSTATIC HYPERPLASIA; RISK FACTORS; SMOKING; TOBACCO, SMOKELESS;

EID: 67449103236     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/568431     Document Type: Article

References (33)

1. J.D. Wilson, The pathogenesis of benign prostatic hyperplasia, Am J Med 68 (1980), 745-746.
2. A.W. Partin, W.F. Page, B.R. Lee, M.G. Sanda, R.N. Miller and P.C. Walsh, Concordance rates for benign prostatic disease among twins suggest hereditary influence, Urology 44 (1994), 646-650.
3. R.O. Roberts, T. Rhodes, L.A. Panser, C.J. Girman, C.G. Chute, H.A. Guess et al., Association between family history of benign prostatic hyperplasia and urinary symptoms: Results of a population-based study, AmJ Epidemiol 142 (1995), 965-973.
4. M.G. Sanda, T.H. Beaty, R.E. Stutzman, B. Childs and P.C. Walsh, Genetic susceptibility of benign prostatic hyperplasia, J Urol 152 (1994), 115-119.
5. M.G. Sanda, C.B. Doehring, B. Binkowitz, T.H. Beaty, A.W. Partin, E. Hale et al., Clinical and biological characteristics of familial benign prostatic hyperplasia, J Urol 157 (1997), 876-879.
6. D.G. Bostwick, A. Pacelli and A. Lopez-Beltran, Molecular biology of prostatic intraepithelial neoplasia, Prostate 29 (1996), 117-134.
7. J.D. Hayes and D.J. Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymestocancer chemoprotectionanddrugresistance, Crit Rev Biochem Mol Biol 30 (1995), 445-600.
8. F.P. Guengerich, R. Their, M. Persmark, J.B. Taylor, S.E. Pemble and B. Ketterer, Conjugation of carcinogens by class glutathione s-transferases: mechanisms and relevance to variations in human risk, Pharmacogenetics 5 (1995), 103-107.
9. R. Medeiros, A. Vasconcelos, S. Costa, D. Pinto, P. Ferreira, F. Lobo et al., Metabolic susceptibility genes and prostate cancer risk in a southern European population: the role of glutathione S-transferases GSTM1, GSTM3, and GSTT1 genetic polymorphisms, Prostate 58 (2004), 414-420.
10. D.S.L. Srivastava, A. Mandhani, B. Mittal and R.D. Mittal, Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India, BJU Int 95 (2005), 170-173.
11. R.D. Mittal, D.K. Mishra and H.K. Bid, Interleukin-1 Receptor Antagonist Polymorphism in Patients with Prostate Cancer and Benign Prostatic Hyperplasia: A Case Control Study from North India, Uro Oncology 4 (2004), 131-134.
12. S.A. Miller, D.D. Dykes and H.F. Polesky, A simple salting out procedure for extracting DNA from human nucleated cells, Nucleic Acids Res 16 (1988), 1215.
13. S.Z. Abdel-Rahman, W.A. Anwar, W.E. Abdel-Aal, H.M. Mostafa and W.W. Au, GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer, Cancer Detect Prev 22 (1998), 129-138.
14. A. Inskip, J. Elexperu-Camiruaga, N. Buxton, P.S. Dias, J. MacIntosh, D.Campbell et al., Identification ofpolymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A, Biochem J 312 (2005), 713-716.
15. C. Acevedo, J.L. Opazo, C. Huidobro, J. Cabezas, J. Iturrieta, L. Quinones Sepulveda, Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people, Prostate 57 (2003), 111-117.
16. M. Murata, T. Shiraishi, K. Fukutome, M. Watanabe, M. Nagao, Y. Kubota et al., Cytochrome P4501A1 and glutathione S-transferase M1 genotypes as risk factors for prostate cancer in Japan, Jpn J Clin Oncol 28 (1998), 657-660.
17. N. Jourenkova-Mironova, A. Voho, C. Bouchardy, H. Wikman, P. Dayer, S. Benhamou et al., Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer risk, Cancer Epidemiol Biomarkers Prev 8 (1999), 185-188.
18. A. Loktionov, M.A. Watson, M. Gunter, W.S. Stebbings, C.T. Speakman, S.A. Bingham et al., Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor, Carcinogenesis 22 (2001), 1053-1060.
19. E. Schnakenberg, R. Breuer, R. Werdin, K. Dreikorn and W. Schloot, Susceptibility genes: GSTM1 and GSTM3 as genetic riskfactors in bladder cancer, Cytogenet Cell Genet 91 (2000), 234-238.
20. N. Jourenkova-Mironova, A. Voho, C. Bouchardy, H. Wikman, P. Dayer, S. Benhamou et al., Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer, Cancer Epidemiol Biomarkers Prev 10 (2001), 229-236.
21. Y. Shi, J.S. Lee and K.M. Galvin, Everything you have ever wanted to know about Yin Yang 1, Biochim Biophys Acta 1332 (1997), F49-66.
22. D.G. Bostwick, A. Pacelli and A. Lopez-Beltran, Molecular biology of prostatic intraepithelial neoplasia, Prostate 29 (1996), 117-134.
23. E.A. Platz, M.F. Leitzmann, E.B. Rimm, W.C. Willett and E. Giovannucci, Alcohol intake, drinking patterns, and risk of prostate cancer in a large prospective cohort study, Am J Epidemiol 159 (2004), 444-453.
24. D.A. Hughes, P.L. Haslam, P.J. Townsend, M. Turner-Warwick et al., Numerical and functional alterations in circulatory lymphocytes in cigarette smokers, Clin Exp Immunol 61 (1985), 459-466.
25. C.J. Meliska, M.E. Stunkard, D.G. Gilbert, R.A. Jensen, J.M. Martinko et al., Immune function in cigarette smokers who quit smoking for 31 days, J Allergy Clin Immunol 95 (1995), 901-910.
26. J. Sunyer, A. Muñoz, Y. Peng, J. Margolick, J.S. Chmiel, J. Oishi et al., Longitudinal relation between smoking and white blood cells, Am J Epidemiol 144 (1996), 734-741.
27. M. Frydenberg, T.M. Foo, A.S. Jones, J. Grace, W.J. Hensley, J. Rogers et al., Benign prostatic hyperplasia-video image analysis and its relationship to androgen and epidermal growth factor receptor expression, J Urol 146 (1991), 872-886.
28. E.A. Plate, E.B. Rimm, I. Kawachi, G.A. Coldite, M.J. Stampfer, WC. Willett et al, Alcohol Consumption, Cigarette Smoking, and Risk of Benign Prostatic Hyperplasia, Am J Epidemiol 149 (1999), 106-15.
29. M.M. Lima Jr, M.N. Oliveira, F. Granja, A.C. Trindade, L.E. De Castro Santos and L.S. Ward, Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and outcome in Brazilian prostate cancer patients, Folia Biol (Praha) 54 (2008), 102-108.
30. A. Gsur, G. Haidinger, S. Hinteregger, G. Bernhofer, G. Schatzl, S. Madersbacher, M. Marberger, C. Vutuc and M. Micksche, Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk, Int J Cancer 95 (2001), 152-155.
31. C. Ntais, A. Polycarpou and J.P. Ioannidis, Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis, Cancer Epidemiol Biomarkers Prev 14 (2005), 176-181.
32. R.J. Mullan, E.J. Bergstralh, S.A. Farmer, D.J. Jacobson, S.J. Hebbring, J.M. Cunningham et al., Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men, Urology 67 (2006), 300-305.
33. R.O. Roberts, E.J. Bergstralh, S.A. Farmer, D.J. Jacobson, S.J. Hebbring, J.M. Cunningham et al., Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia, Prostate 66 (2006), 392-404.